Your choice depends on your specific skin goals
Abbreviations DUBs: Deubiquitinases GPX4: Glutathione peroxidase SLC7A11: Solute Carrier Family 7 Member 11 PROTACs: Proteolysis TArgeting Chimeras Ub: Ubiquitin FBXW7: F-box and WD repeat-domain containing 7 SOX9: SRY-box transcription factor 9 SOCS2: Suppressor of Cytokine Signaling 2 TRIM21: Tripartite Motif Containing 21 VDAC2: Voltage-dependent anion channel 2 SMURF2: Smad ubiquitination regulatory factor 2 cGAS: Cyclic GMP-AMP Synthase STING: Stimulator of Interferon Genes USP14: Ubiquitin specific peptidase 14 ALKBH5: AlkB homolog 5 NHEJ: Non-homologous end joining TRAF4: TNF receptor-associated factor 4 MCL-1: Myeloid cell leukemia-1 UBE2T: Ubiquitin-conjugating enzyme E2T FANCD2: FA group D2 protein H2Bub1: Monoubiquitylation of histone H2B SUPT16H: Suppressor of Ty homolog-16 EMT: Epithelial-mesenchymal transition OTUD5: OTU deubiquitinase 5 EZH2: Enhancer of zeste homolog 2 TNBC: Triple negative breast cancer KAP1: KRAB domain-associated protein 1 MDM2: Murine double minute 2 KLF5: Krppel-like factor 5 SENP: Sentrin-specific protease RUVBL1: RuvB-like protein 1 DTL: Dentideless IGF2BP2: Insulin-like growth factor 2 mRNA-binding protein 2 PTM: Post-translational modification NSCLC: Non-small cell lung cancer ESR1: Estrogen receptor CTH: Cystathionase CRLs: Cullin-RING complexes PDOs: Patient-derived organoids HRR: Homologous recombination repair NCTD: Norcantharidin HNSCC: Head and neck squamous cell carcinoma References Huang RX, Zhou PK
In highly specialised settings, a clinician might theoretically consider combining a GH-axis modulator with an incretin-based therapy for a patient with a specific, well-characterised metabolic phenotype for instance, significant visceral adiposity in the context of HIV-associated lipodystrophy who has not responded adequately to standard treatments
The contributions of cartilage endplate composition and vertebral bone marrow fat to intervertebral disc degeneration in patients with chronic low back pain
A host of studies have highlighted the importance of AMPK inactivation in the pathogenesis of diabetic cardiomyopathy ( 2 S might protect cardiomyocytes from hyperglycemia stress through AMPK-mediated inhibition of mTOR
4d), indicating that part of the protective effect observed with NAC requires GSH synthesis
